Effect of alprostadil on the treatment of diabetic nephropathy
- VernacularTitle:前列地尔治疗糖尿病肾病的临床研究
- Author:
Xuping WANG
;
Peiyan SONG
;
Yusong CHEN
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathies;
Albuminuria;
Alprostadil
- From:
Chinese Journal of Primary Medicine and Pharmacy
2008;15(10):1666-1667
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effectiveness of alprostedil in treatment of diabetic nephropathy and the mechanism of the renal protection of the drug. Methods One hundred patients with diabetic nephropathy due to diabetes mellitus were randomly divided into 2 groups ,50 in treatment group ,and 50 as controls, alprostadil was used intravenously in the Treatment Group for 12 day while routine management of diabetes such as food intake control,physical exercises and oral drugs or injection of insulin was conducted in both of the 2 groups. Urinary albumin were employed for evaluation as well as the side-effects. Results By the end of the trial, urinary albumin was decreased significantly compared with those before intravenous alprostadil treatment or with those in the control group (P<0.05). Conclusion Urinary albumin was decreased significantly after intravenous alprostadil. Therefore,it is a safe and effective drug in the treatment of diabetic nephropathy.
